5 Cheap Pharmaceutical Stocks For 2022
Evolus, Inc. (NASDAQ:EOLS) operates as a medical aesthetics firm.
Kaleido Biosciences Inc. (KLDO)
Market is closed
News
- Displaying 8
5 Biotech Penny Stocks to Buy Now
Kaleido Biosciences, Inc. (NASDAQ:KLDO) is a clinical-stage healthcare firm that develops microbiome metabolic therapies.
Is Kaleido BioSciences, Inc. (KLDO) A Good Stock To Buy?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Hedge Fund and Insider Trading News: Stanley Druckenmiller, Starboard Value LP, AQR Capital Management, Falcon Edge Capital Management, Asia Research & Capital Management, Amphenol Corporation (APH), United States Cellular Corp (USM), and More
AQR Capital Management (AQR) has launched the AQR Diversifying Strategies Fund, which is designed to be a single solution to gain exposure to liquid alternatives with attractive long-term risk-adjusted...
Kaleido BioSciences, Inc. (KLDO): Are Hedge Funds Right About This Stock?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Here is What Hedge Funds Think About Kaleido BioSciences, Inc. (KLDO)
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China.
Kaleido BioSciences, Inc. (KLDO) Is Burning These Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund and Insider Trading News: David Einhorn, AlphaOne Capital Partners, Dalton Investments, Barington Capital, Kaleido Biosciences Inc (KLDO), EMC Insurance Group (EMCI), and More
One of Hyundai Home Shopping Network Corp.’s largest investors is calling for the company to return about $365 million in cash to shareholders, realign executive compensation and split off some of its...
Billionaire Hedge Funds
